>>Signaling Pathways>> Others>>Hydrocarbon chain derivative 1 (6,6'-Oxybis[2,2-dimethyl-1-hexanol])

Hydrocarbon chain derivative 1 (6,6'-Oxybis[2,2-dimethyl-1-hexanol]) (Synonyms: 6,6'-Oxybis[2,2-dimethyl-1-hexanol])

Catalog No.GC31542

탄화수소 사슬 유도체 1(6,6'-Oxybis[2,2-디메틸-1-헥산올])은 지질 합성에 대한 억제 활성을 갖는 활성 화합물입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Hydrocarbon chain derivative 1 (6,6'-Oxybis[2,2-dimethyl-1-hexanol]) Chemical Structure

Cas No.: 300762-25-8

Size 가격 재고 수량
1mg
US$717.00
재고 있음
5mg
US$1,434.00
재고 있음
10mg
US$2,436.00
재고 있음
20mg
US$4,302.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Hydrocarbon chain derivative 1 is an active compound, with inhibitory activities against lipid synthesis.

Hydrocarbon chain derivative 1 is well tolerated with mild liver effects at 2000 mg/kg in rats[1]. Hydrocarbon chain derivative 1 shows inhibitory effect on lipid synthesis, with an IC50 of 11 μM[2].

[1]. Oniciu DC, et al. Influence of various central moieties on the hypolipidemic properties of long hydrocarbon chain diols and diacids. J Med Chem. 2006 Jan 12;49(1):334-48. [2]. Oniciu DC, et al. Long hydrocarbon chain diols and diacids with central ether or ketone moieties that favorably alter lipid disorders. Pharmazie. 2006 Feb;61(2):157-65.

리뷰

Review for Hydrocarbon chain derivative 1 (6,6'-Oxybis[2,2-dimethyl-1-hexanol])

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Hydrocarbon chain derivative 1 (6,6'-Oxybis[2,2-dimethyl-1-hexanol])

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.